Biosimilar Clinical Development: Scientific Considerations and New Methodologies
Besorgungstitel - wird vorgemerkt | Lieferzeit: Besorgungstitel - Lieferbar innerhalb von 10 Werktagen I
225,80 €*
Alle Preise inkl. MwSt.|Versandkostenfrei
ISBN-13:
9781482231694
Veröffentl:
2016
Erscheinungsdatum:
15.09.2016
Seiten:
248
Autor:
Kerry B Barker
Gewicht:
590 g
Format:
239x163x15 mm
Sprache:
Englisch
Beschreibung:
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Biosimilars for Drug Development. Regulatory Requirements on Biosimilars. System Biology in the Context of Biosimilars. Clinical Considerations on Biosimilars. Large Molecules Complete Molecular Confidence (CMC) Development Strategy. Immunogenicity. Interchangeability. Bridging a New Biologic to Its Reference Biologic. How to Account Covariate Effect to Show Non-Inferiority in Biosimilars. Novel Method in Inference of Equivalence in Biosimilars. Multiplicity Adjustment in Equivalence Using Two One-Sided Tests. Bayesian Methods in Biosimilar Studies.
Kunden Rezensionen
Mehr zum Thema
Folgen Sie uns auf:
